Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1 Meeting Abstract
| Authors: | Friedlander, M. L.; Moore, K.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Lisyanskaya, A.; Floquet, A.; Leary, A.; Sonke, G. S.; Gourley, C.; Banerjee, S.; Oza, A.; González-Martín, A.; Aghajanian, C.; Bradley, W.; Holmes, E.; Lowe, E. S.; Disilvestro, P. |
| Abstract Title: | Maintenance olaparib for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm): 5-year (y) follow-up (f/u) from SOLO1 |
| Meeting Title: | ESMO Asia Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2020 Nov 20-22 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-11-01 |
| Start Page: | S1334 |
| Language: | English |
| ACCESSION: | WOS:000600988900237 |
| DOI: | 10.1016/j.annonc.2020.10.228 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 234O -- Source: Wos |
